发明名称 |
COMBINED USE OF AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST AND AN ANTI-MUSCARINIC AGENT |
摘要 |
The combined use of (R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide (tamsulosin), or its pharmaceutically acceptable salt, and (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt, for the preparation of a medicament for the improvement of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTSBPH) with a substantial storage component is provided. |
申请公布号 |
EP2352495(A1) |
申请公布日期 |
2011.08.10 |
申请号 |
EP20090771289 |
申请日期 |
2009.11.04 |
申请人 |
ASTELLAS IRELAND CO., LTD. |
发明人 |
VAN CHARLDORP, KARIN JULIETTE;BOSMAN, BRIGITTE JOHANNA FANNY;KLAVER, MONIQUE MARIA ALIDA;GARCIA HERNANDEZ, ALBERTO;DROGENDIJK, TENNIS EDWIN |
分类号 |
A61K31/18;A61K31/439 |
主分类号 |
A61K31/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|